A PHASE I/II EFFICACY AND SAFETY STUDY OF SU011248 IN PATIENTS WITH RECURRENT OR METASTATIC NON-NASOPHARYNGEAL HEAD AND NECK CANCER
Latest Information Update: 20 May 2011
At a glance
- Drugs Sunitinib (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
Most Recent Events
- 20 May 2011 New trial record